Essex Bio-Technology Limited Stock Deutsche Boerse AG
Equities
EB51
KYG312371035
Pharmaceuticals
Sales 2022 | 1.32B 169M 156M 230M | Sales 2023 | 1.71B 218M 202M 298M | Capitalization | 1.41B 181M 167M 246M |
---|---|---|---|---|---|
Net income 2022 | 225M 28.8M 26.57M 39.24M | Net income 2023 | 275M 35.2M 32.47M 47.96M | EV / Sales 2022 | 1.78 x |
Net cash position 2022 | 53.76M 6.88M 6.35M 9.37M | Net cash position 2023 | 221M 28.29M 26.1M 38.54M | EV / Sales 2023 | 0.7 x |
P/E ratio 2022 |
11
x | P/E ratio 2023 |
5.31
x | Employees | 1,481 |
Yield 2022 |
1.55% | Yield 2023 |
3.61% | Free-Float | 45.97% |
Managers | Title | Age | Since |
---|---|---|---|
Hai Zhou Fang
CEO | Chief Executive Officer | 58 | 00-07-30 |
Qi Xue
CTO | Chief Tech/Sci/R&D Officer | 63 | 18-04-08 |
Hian Leng Ngiam
BRD | Director/Board Member | 40 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mia Je Ngiam
FOU | Founder | 70 | 99-01-31 |
Lai Man Yau
BRD | Director/Board Member | 60 | 00-12-31 |
Mee Mooi Yeow
BRD | Director/Board Member | 72 | 04-09-29 |
1st Jan change | Capi. | |
---|---|---|
+4.57% | 96.72B | |
+5.66% | 41.43B | |
-12.80% | 32.7B | |
+80.99% | 29.06B | |
-15.53% | 15.38B | |
-8.70% | 12.97B | |
-12.22% | 11.36B | |
+183.25% | 9.9B | |
+3.60% | 8.93B |